Cas:6366-70-7 N6-Cbz-L-Lysine benzyl ester hydrochloride manufacturer & supplier

Chemical Name:N6-Cbz-L-Lysine benzyl ester hydrochloride

CAS.NO:6366-70-7

Synonyms:L-Lysine, N-[(phenylmethoxy)carbonyl]-, phenylmethyl ester, hydrochloride (1:1);MFCD00038981;EINECS 228-859-9;Benzyl N-[(benzyloxy)carbonyl]-L-lysinate hydrochloride (1:1);N6-Carbobenzyloxy-L-lysine Benzyl Ester Hydrochloride;H-Lys(Z)-OBzl·HCl

Molecular Formula:C₂₁H₂₇ClN₂O₄

Molecular Weight:406.903

HS Code:2924299090

Physical and Chemical Properties:

Melting point:138-140ºC

Boiling point:511.7ºC at 760 mmHg

Density:1.163g/cm3

Index of Refraction:1.562

PSA:90.65000

Exact Mass:406.165924

LogP:5.04700

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like L-Lysine, N-[(phenylmethoxy)carbonyl]-, phenylmethyl ester, hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,H-Lys(Z)-OBzl·HCl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 228-859-9 Use and application,H-Lys(Z)-OBzl·HCl technical grade,usp/ep/jp grade.

Related News: Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. N6-Cbz-L-Lysine benzyl ester hydrochloride manufacturer With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow. N6-Cbz-L-Lysine benzyl ester hydrochloride supplier But the ban from Italy remains, Joseph Wu, Taiwan��s foreign minister, said on Sunday. N6-Cbz-L-Lysine benzyl ester hydrochloride vendor Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. N6-Cbz-L-Lysine benzyl ester hydrochloride factory With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.